A detailed history of Avion Wealth transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Avion Wealth holds 6 shares of CRL stock, worth $1,194. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 6 -0.0%
Holding current value
$1,194
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

BUY
$164.52 - $238.84 $493 - $716
3 Added 100.0%
6 $1,000
Q3 2023

Oct 20, 2023

SELL
$194.44 - $217.61 $388 - $435
-2 Reduced 40.0%
3 $0
Q2 2023

Jul 14, 2023

BUY
$183.71 - $210.25 $367 - $420
2 Added 66.67%
5 $1,000
Q2 2022

Aug 11, 2022

BUY
$204.13 - $302.4 $612 - $907
3 New
3 $1,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.